Globe has also announced that Molnupiravir, the investigational drug used to prevent the spread of COVID-19 is now officially available on the HealthNow app. Molnupiravir helped cut the rate of hospitalization and death by half in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to reports. COVID-19 positive patients interested in Molnupiravir may consult with a doctor on the HealthNow app to check eligibility. Read more in our articles including "Globe Group continues internet and health support amid rise of Covid cases" and "Smartphones Under P10,000 | Q2 2026".
Globe has also announced that Molnupiravir, the investigational drug used to prevent the spread of COVID-19 is now officially available on the HealthNow app. Molnupiravir helped cut the rate of hospitalization and death by half in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to reports.
COVID-19 positive patients interested in Molnupiravir may consult with a doctor on the HealthNow app to check eligibility.
Our coverage of molnupiravir includes: "Globe Group continues internet and health support amid rise of Covid cases"; "Smartphones Under P10,000 | Q2 2026"; "Infinix HOT 70 now available with Dynamic Shine design". Each article provides unique insights and information.